# Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)

> **NCT06099756** · — · UNKNOWN · sponsor: **Measure Labs, Inc.** · enrollment: 2000 (estimated)

## Conditions studied

- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06099756
- **Lead sponsor:** Measure Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-26
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099756, "Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06099756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*